MeSH term
Frequency | Condition_Probility | Humans | 44 | 0.0 |
Posture/*physiology | 2 | 6.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 14 | 0.0 |
Female | 22 | 0.0 |
Mice | 10 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Adult | 13 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Infant | 5 | 0.0 |
Male | 17 | 0.0 |
*Osmotic Pressure | 4 | 33.0 |
Water-Electrolyte Balance | 2 | 3.0 |
Comparative Study | 8 | 0.0 |
Time Factors | 5 | 0.0 |
Base Sequence | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Aged | 11 | 0.0 |
*Colloids | 3 | 25.0 |
Middle Aged | 13 | 0.0 |
Osmotic Pressure | 12 | 19.0 |
Pressure | 2 | 1.0 |
Water-Electrolyte Balance/physiology | 2 | 5.0 |
Mammary Neoplasms, Experimental/*genetics | 2 | 28.0 |
Rats | 4 | 0.0 |
Colloids | 6 | 25.0 |
Predictive Value of Tests | 2 | 0.0 |
Serum Albumin/analysis | 2 | 1.0 |
Treatment Outcome | 2 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Osmolar Concentration | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Cholesterol/*metabolism | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Blood Proteins/analysis | 2 | 1.0 |
Hematocrit | 3 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
English Abstract | 6 | 0.0 |
Postoperative Period | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Fluid Therapy | 3 | 14.0 |
Plasma Volume | 2 | 6.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Ovum/immunology | 3 | 6.0 |
Methods | 2 | 0.0 |
Infusions, Parenteral | 2 | 1.0 |
Schistosoma japonicum/immunology | 2 | 22.0 |
Colloids/*analysis | 2 | 100.0 |
Schistosomiasis/*immunology | 2 | 11.0 |
*Precipitin Tests | 3 | 42.0 |
Schistosomiasis/*diagnosis/immunology | 2 | 66.0 |
Bed Rest | 2 | 18.0 |
Pregnancy | 2 | 0.0 |
Immunoglobulin A/analysis | 2 | 1.0 |
Immunoglobulin G/analysis | 2 | 0.0 |
Immunoglobulin M/analysis | 2 | 0.0 |
Ovum/*immunology | 2 | 16.0 |
Drug Therapy, Combination | 3 | 0.0 |
Blood Pressure | 2 | 0.0 |
Remission, Spontaneous | 2 | 2.0 |
